CC (The Chemours Company)
Insider Trading Activity
Every open-market purchase and sale reported by CC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-13 | Calderon Gerardo Familiar | See Remarks | Buy | — | — |
| 2026-08-13 | Denise Dignam | Chief Executive Officer | Buy | — | — |
| 2026-08-13 | David Will | Chief Accounting Officer | F | — | — |
| 2026-08-11 | Michael Robert Foley | See Remarks | Buy | — | — |
| 2026-08-11 | Alister Cowan | Director | Buy | — | — |
| 2026-08-11 | Joseph T. Martinko | See Remarks | Buy | — | — |
| 2026-08-11 | MARY B CRANSTON | Director | Buy | — | — |
| 2026-08-10 | SHANE HOSTETTER | Chief Financial Officer | Buy | — | — |
| 2026-08-10 | SHANE HOSTETTER | Chief Financial Officer | F | — | — |
| 2026-08-04 | Denise Dignam | Chief Executive Officer | F | — | — |
| 2026-08-04 | Joseph T. Martinko | See Remarks | F | — | — |
| 2026-08-04 | Kristine M Wellman | SVP, GC & Corp. Secretary | F | — | — |
| 2026-08-04 | Calderon Gerardo Familiar | See Remarks | F | — | — |
| 2026-07-01 | COURTNEY MATHER | Director | A | — | — |
| 2026-05-08 | Pamela Fletcher | Director | A | — | — |
| 2026-05-08 | Alister Cowan | Director | A | — | — |
| 2026-05-08 | George R Brokaw | Director | A | — | — |
| 2026-05-08 | COURTNEY MATHER | Director | A | — | — |
| 2026-05-08 | Joseph Daniel Kava | Director | A | — | — |
| 2026-05-08 | Erin N Kane | Director | A | — | — |
| 2026-05-08 | MARY B CRANSTON | Director | A | — | — |
| 2026-05-08 | Sean D Keohane | Director | A | — | — |
| 2026-05-08 | LIVINGSTON SATTERTHWAITE | Director | A | — | — |
| 2026-05-08 | Leslie M Turner | Director | A | — | — |
| 2026-04-01 | COURTNEY MATHER | Director | A | — | — |
| 2026-03-03 | SHANE HOSTETTER | Chief Financial Officer | MIXED | — | — |
| 2026-03-03 | Michael Robert Foley | See Remarks | A | — | — |
| 2026-03-03 | Denise Dignam | Chief Executive Officer | MIXED | — | — |
| 2026-03-03 | Joseph T. Martinko | See Remarks | MIXED | — | — |
| 2026-03-03 | Kristine M Wellman | SVP, GC & Corp. Secretary | MIXED | — | — |
| 2026-03-03 | David Will | Chief Accounting Officer | MIXED | — | — |
| 2026-03-03 | Calderon Gerardo Familiar | See Remarks | MIXED | — | — |
| 2026-02-26 | Kristine M Wellman | SVP, GC & Corp. Secretary | MIXED | — | — |
| 2026-02-26 | Denise Dignam | Chief Execitive Officer | MIXED | — | — |
| 2026-01-05 | COURTNEY MATHER | Director | A | — | — |
| 2026-01-05 | LIVINGSTON SATTERTHWAITE | Director | A | — | — |
| 2025-10-02 | COURTNEY MATHER | Director | A | — | — |
| 2025-10-02 | LIVINGSTON SATTERTHWAITE | Director | A | — | — |
| 2025-09-03 | Calderon Gerardo Familiar | Pres Advanced Performance Mat | F | — | — |
| 2025-08-14 | David Will | Chief Accounting Officer | F | — | — |
| 2025-08-12 | Denise Dignam | President & CEO | Buy | — | — |
| 2025-08-08 | SHANE HOSTETTER | Chief Financial Officer | F | — | — |
| 2025-08-05 | Kristine M Wellman | SVP, GC & Corp. Secretary | F | — | — |
| 2025-08-05 | Joseph T. Martinko | See Remarks | F | — | — |
| 2025-08-05 | Denise Dignam | President & CEO | F | — | — |
| 2025-08-05 | Calderon Gerardo Familiar | See Remarks | F | — | — |
| 2025-07-02 | LIVINGSTON SATTERTHWAITE | Director | A | — | — |
| 2025-07-02 | COURTNEY MATHER | Director | A | — | — |
| 2025-06-04 | Damian Gumpel | See Remarks | Buy | — | — |
| 2025-05-21 | SHANE HOSTETTER | Chief Financial Officer | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | SVP, CFO | 381,345 | — |
| — | Chief Executive Officer | 339,916 | — |
| — | Director | 317,108 | — |
| — | President and CEO | 299,109 | — |
| — | SVP, GC & Corp. Secretary | 226,161 | — |
| — | President - Fluoroproducts | 190,022 | — |
| — | President, Titan Tech Chem Sol | 147,429 | — |
| — | President, Titanium Tech | 146,983 | — |
| — | See Remarks | 123,879 | — |
| — | Director | 113,140 | — |
| — | Director | 111,883 | — |
| — | Director | 107,195 | — |
| — | Chief Financial Officer | 99,347 | — |
| — | Director | 97,636 | — |
| — | Sr. VP Human Resources | 87,805 | — |
| — | President, Chemical Solutions | 84,901 | — |
| — | SVP, People and Health Service | 84,253 | — |
| — | Director | 83,129 | — |
| — | Director | 81,004 | — |
| — | SVP, GC & Corp. Secretary | 74,418 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CC quote page; the site-wide leaderboard is on the insider transactions hub.